Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.

• click to rate

  Posted by Two Blokes April 23, 2025 - Filed in Stock - 22 views
  
  Iovance Biotherapeutics (IOVA 4.38%) is a stock that many investors think has a lot of upside. A year ago, regulators approved its cellular therapy, Amtagvi, to treat unresectable (inoperable) or metastatic melanoma.